A photoresponsive degradable tumor koningine precursor compound and its preparation and application
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- MENGCHAO HEPATOBILIARY HOSPITAL OF FUJIAN MEDICAL UNIV
- Publication Date
- 2020-03-10
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
[0001] (1) Technical field
[0002] The invention relates to a photoresponsive degradable tumor cloningin precursor compound, a preparation method and an application thereof.
[0003] (2) Background technology
[0004] Chlorambucil (Chlorambucil) is an antineoplastic drug that acts on the structure of DNA. It is mainly used for chronic lymphocytic leukemia, and is also suitable for malignant lymphoma, multiple myeloma, macroglobulinemia, ovarian cancer. However, the small-molecule Liukonin lacks selectivity to tumor tissue and has strong bone marrow and nerve cell toxic side effects, so it generally cannot be used directly. In recent years, the development of a controlled release system for Liukonin is an effective way to improve efficacy and reduce side effects.
[0005] Among many environment-sensitive drug controlled release strategies, the light-controlled drug controlled release system can actively and precisely regulate the target molecule to achieve "timed, fixed-point...